When Mel Gibson disclosed the contentious methods his friends used to treat their terminal cancers, Joe Rogan was taken aback.
Gibson said that three of his pals had been diagnosed with stage four cancer and that they all had “some serious stuff going on” during the most recent episode of the Joe Rogan Experience.
According to Gibson, they took fenbendazole and ivermectin, which are medications often used to treat illnesses brought on by roundworms, threadworms, and other parasites.
The star of Lethal Weapon then made the shocking assertion that none of the three buddies “have cancer at the moment.”
‘This stuff works, man,’ he added.
Larger trials have not supported the preliminary findings that ivermectin, when used in conjunction with other treatments, can help reduce tumor size.
According to certain studies, fenbendazole, which is marketed under the brands Panacur and Safe-Guard, inhibits the proliferation of cancer cells, even some of the most aggressive ones.
Although preliminary findings are promising, experts warned that fenbendazole can have major adverse effects. Additionally, they caution that avoiding conventional therapies may be fatal.
Gibson said: ‘I don’t believe that there is anything that can afflict mankind that hasn’t got a natural cure for it. It just makes sense to me.
‘I couldn’t prove that, but I just believe that. There’s got to be something that cures things.’
‘This stuff does work, which is strange because it’s not profit,’ Rogan continued, referring to both medicines.
Additionally, he noted that both medications are contentious and speculated that because normal cancer therapies are more profitable, health authorities might be promoting them.
‘When you hear about things that are demonized and they turn out to be effective, you always wonder, “What is going on here?” Rogan continued. “How have our medical institutions failed us so that things that do cure you are not promoted because they’re not profitable?”‘
Although prices vary, 20 pills without insurance are anticipated to cost around $90.
